- By ICR Secretariat
- Posted Thursday, April 14, 2022
Hundreds of urothelial cancer patients to receive new treatment
https://www.pharmatimes.com/news/hundreds_of_urothelial_cancer_patients_to_receive_new_treatment_1389878
NICE recommends avelumab as treatment for adults with locally advanced or metastatic urothelial cancer
The oldest independent membership-led professional body for clinical researchers across the globe.
Latest Posts
- FDA rejects two China-developed cancer drugs 19/05/2022 03:45 PM
- University launches hub for pregnant women with pre-existing medical conditions 19/05/2022 03:44 PM
- Roche cancer immunotherapy fails another trial, casting doubt on emerging drug class 19/05/2022 03:42 PM
Useful Links
Contact Us
Suite 11a, Cedar Court
Grove Park
White Waltham
Maidenhead
SL6 3LW
info@icr-global.org